Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Malignant Solid Tumors 1

Interventions

Specimen Handling 154pembrolizumab 133Magnetic Resonance Spectroscopy 121Cyclophosphamide 120Biopsy 108fludarabine 92Nivolumab 61Carboplatin 55Radiotherapy 49Cisplatin 49Gemcitabine 48venetoclax 44Paclitaxel 43Cetuximab 41fludarabine phosphate 40Ipilimumab 36Fluorouracil 35atezolizumab 34Bevacizumab 33durvalumab 30Radiation 30Oxaliplatin 29X-Rays 28Leucovorin 28Dexamethasone 28Cytarabine 27Azacitidine 27Irinotecan 26Radiosurgery 24Injections 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Premedication × 90 days × Clear all
NCT06573294 2026-05-20

Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors

Genmab

Phase 1 Terminated
23 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡